BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31628340)

  • 21. The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System.
    Sullivan PS; Hirschowitz SL; Fung PC; Apple SK
    Cancer Cytopathol; 2014 Dec; 122(12):866-72. PubMed ID: 25078420
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of Malignancy and Risk of Neoplasia in the Bethesda Indeterminate Categories: Study on 4,532 Thyroid Fine-Needle Aspirations from a Single Institution in India.
    Mahajan S; Srinivasan R; Rajwanshi A; Radotra B; Panda N; Dey P; Gupta N; Nijhawan R
    Acta Cytol; 2017; 61(2):103-110. PubMed ID: 28407624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A nomogram for predicting malignancy in thyroid nodules diagnosed as atypia of undetermined significance/follicular lesions of undetermined significance on fine needle aspiration.
    Yoon JH; Lee HS; Kim EK; Moon HJ; Kwak JY
    Surgery; 2014 Jun; 155(6):1006-13. PubMed ID: 24630147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in risk of malignancy and management recommendations in subcategories of thyroid nodules with atypia of undetermined significance or follicular lesion of undetermined significance: the role of ultrasound-guided core-needle biopsy.
    Choi YJ; Baek JH; Ha EJ; Lim HK; Lee JH; Kim JK; Song DE; Shong YK; Hong SJ
    Thyroid; 2014 Mar; 24(3):494-501. PubMed ID: 23947771
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low Malignancy Rates in Fine-Needle Aspiration Cytologies in a Primary Care Setting in Germany.
    Eszlinger M; Ullmann M; Ruschenburg I; Böhme K; Görke F; Franzius C; Adam S; Molwitz T; Landvogt C; Amro B; Hach A; Feldmann B; Graf D; Wefer A; Niemann R; Bullmann C; Klaushenke G; Santen R; Tönshoff G; Ivancevic V; Kögler A; Bell E; Lorenz B; Kluge G; Hartenstein C; Paschke R
    Thyroid; 2017 Nov; 27(11):1385-1392. PubMed ID: 28982301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules.
    Elomami A; Elhag SA; Alseddeeqi E
    Acta Cytol; 2021; 65(3):205-212. PubMed ID: 33524971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic Performance of Ultrasound Patterns by K-TIRADS and 2015 ATA Guidelines in Risk Stratification of Thyroid Nodules and Follicular Lesions of Undetermined Significance.
    Hong HS; Lee JY
    AJR Am J Roentgenol; 2019 Aug; 213(2):444-450. PubMed ID: 31039023
    [No Abstract]   [Full Text] [Related]  

  • 28. Core-needle biopsy versus repeat fine-needle aspiration for thyroid nodules initially read as atypia/follicular lesion of undetermined significance.
    Choi YJ; Baek JH; Suh CH; Shim WH; Jeong B; Kim JK; Song DE; Kim TY; Chung KW; Lee JH
    Head Neck; 2017 Feb; 39(2):361-369. PubMed ID: 27704650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypia of undetermined significance in thyroid fine-needle aspiration cytology: prediction of malignancy by US and comparison of methods for further management.
    Lee KH; Shin JH; Oh YL; Hahn SY
    Ann Surg Oncol; 2014 Jul; 21(7):2326-31. PubMed ID: 24566858
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prediction of malignant risk in the category "atypia of undetermined significance/follicular lesion of undetermined significance" of the Bethesda System for Reporting Thyroid Cytopathology using subcategorization and BRAF mutation results.
    Hyeon J; Ahn S; Shin JH; Oh YL
    Cancer Cytopathol; 2014 May; 122(5):368-76. PubMed ID: 24591408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nodule size is an independent predictor of malignancy in mutation-negative nodules with follicular lesion of undetermined significance cytology.
    Mehta RS; Carty SE; Ohori NP; Hodak SP; Coyne C; LeBeau SO; Tublin ME; Stang MT; Johnson JT; McCoy KL; Nikiforova MN; Nikiforov YE; Yip L
    Surgery; 2013 Oct; 154(4):730-6; discussion 736-8. PubMed ID: 24074409
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Repeat fine-needle aspiration can be performed at 6 months or more after initial atypia of undetermined significance or follicular lesion of undetermined significance results for thyroid nodules 10 mm or larger.
    Koh J; Kim EK; Kwak JY; Yoon JH; Moon HJ
    Eur Radiol; 2016 Dec; 26(12):4442-4448. PubMed ID: 26965502
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reproducibility of atypia of undetermined significance/follicular lesion of undetermined significance category using the bethesda system for reporting thyroid cytology when reviewing slides from different institutions: A study of interobserver variability among cytopathologists.
    Padmanabhan V; Marshall CB; Akdas Barkan G; Ghofrani M; Laser A; Tolgay Ocal I; David Sturgis C; Souers R; Kurtycz DF
    Diagn Cytopathol; 2017 May; 45(5):399-405. PubMed ID: 28217980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic Lobectomy for Bethesda III Thyroid Nodules: Pathological Outcomes and Risk Factors for Malignancy.
    Walters BK; Garrett SL; Aden JK; Williams GM; Butler-Garcia SL; Newberry TR; Mckinlay AJ
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1064-1068. PubMed ID: 33567896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcategorization of atypia of undetermined significance/follicular lesion of undetermined significance (AUS/FLUS): a study applying Thyroid Imaging Reporting and Data System (TIRADS).
    Yoon JH; Kwon HJ; Kim EK; Moon HJ; Kwak JY
    Clin Endocrinol (Oxf); 2016 Aug; 85(2):275-82. PubMed ID: 26639612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thyroid Atypia/Follicular Lesion of Undetermined Significance: Attitudes towards the Diagnosis of Bethesda System III Nodules.
    Estrada Muñoz L; Díaz Del Arco C; Ortega Medina L; Fernández Aceñero MJ
    Acta Cytol; 2017; 61(1):21-26. PubMed ID: 27852075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical Outcome and Malignant Risk Factors in Patients With Thyroid Nodule Classified as Bethesda Category III.
    Huang J; Shi H; Song M; Liang J; Zhang Z; Chen X; Liu Y; Wang S; Wu Z
    Front Endocrinol (Lausanne); 2021; 12():686849. PubMed ID: 34594299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Malignancy risk for solitary and multiple nodules in Hürthle cell-predominant thyroid fine-needle aspirations: A multi-institutional study.
    Wong KS; Jo VY; Lowe AC; Faquin WC; Renshaw AA; Shah AA; Roh MH; Stelow EB; Krane JF
    Cancer Cytopathol; 2020 Jan; 128(1):68-75. PubMed ID: 31751003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of malignancy in thyroid nodules determined to be follicular lesions of undetermined significance on fine-needle aspiration.
    Teixeira GV; Chikota H; Teixeira T; Manfro G; Pai SI; Tufano RP
    World J Surg; 2012 Jan; 36(1):69-74. PubMed ID: 22057754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcome of thyroid nodules characterized as atypia of undetermined significance or follicular lesion of undetermined significance and correlation with Ultrasound features and BRAF(V600E) mutation analysis.
    Jeong SH; Hong HS; Lee EH; Cha JG; Park JS; Kwak JJ
    AJR Am J Roentgenol; 2013 Dec; 201(6):W854-60. PubMed ID: 24261392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.